Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5645 USD | +3.71% |
|
-15.76% | -32.68% |
Jul. 01 | X4 Pharmaceuticals, Inc.(NasdaqCM:XFOR) dropped from Russell 3000E Value Index | CI |
Jul. 01 | X4 Pharmaceuticals, Inc.(NasdaqCM:XFOR) dropped from Russell 2000 Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.68% | 94.8M | |
+15.58% | 121B | |
+16.60% | 110B | |
+18.40% | 25.98B | |
-24.33% | 19.27B | |
-18.31% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- XFOR Stock
- News X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome